Summit Therapeutics Inc.
SMMT
$17.46
-$1.45-7.67%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 412.35M | 486.90M | 325.47M | 156.68M | 186.24M |
| Total Receivables | 557.00K | 660.00K | 953.00K | 945.00K | 848.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 10.52M | 2.41M | 2.05M | 5.32M | 2.62M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 325.00K | 323.00K | 320.00K | 317.00K | -- |
| Total Current Assets | 423.75M | 490.29M | 328.79M | 163.27M | 189.71M |
|
|
|||||
| Total Current Assets | 423.75M | 490.29M | 328.79M | 163.27M | 189.71M |
| Net Property, Plant & Equipment | 7.40M | 8.24M | 8.94M | 9.55M | 6.06M |
| Long-term Investments | 1.86M | 1.99M | 1.88M | 1.88M | 1.89M |
| Goodwill | 1.86M | 1.99M | 1.88M | 1.88M | 1.89M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.55M | 2.33M | 2.24M | 2.09M | 5.28M |
| Total Assets | 435.56M | 502.85M | 341.86M | 176.78M | 202.95M |
|
|
|||||
| Total Accounts Payable | 4.64M | 3.25M | 3.34M | 6.37M | 2.67M |
| Total Accrued Expenses | 31.53M | 26.44M | 32.33M | 12.58M | 14.21M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.77M | 28.29M | 103.69M | 3.70M | 2.81M |
| Total Finance Division Other Current Liabilities | 1.80M | 1.03M | 806.00K | 788.00K | 717.00K |
| Total Other Current Liabilities | 1.80M | 1.03M | 806.00K | 788.00K | 717.00K |
| Total Current Liabilities | 41.73M | 59.01M | 140.17M | 23.44M | 20.41M |
|
|
|||||
| Total Current Liabilities | 41.73M | 59.01M | 140.17M | 23.44M | 20.41M |
| Long-Term Debt | -- | -- | -- | 100.00M | 100.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.45M | 4.21M | 5.02M | 5.82M | 3.29M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.63M | 1.72M | 1.60M | 3.31M | 1.56M |
| Total Liabilities | 46.81M | 64.93M | 146.78M | 132.57M | 125.26M |
|
|
|||||
| Common Stock & APIC | 1.61B | 1.59B | 1.29B | 1.08B | 1.07B |
| Retained Earnings | -1.21B | -1.15B | -1.10B | -1.04B | -993.26M |
| Treasury Stock & Other | -2.29M | -2.31M | -2.50M | -2.45M | -2.45M |
| Total Common Equity | 388.75M | 437.92M | 195.08M | 44.21M | 77.69M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 388.75M | 437.92M | 195.08M | 44.21M | 77.69M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 388.75M | 437.92M | 195.08M | 44.21M | 77.69M |
|
|
|||||
